Bayer HealthCare Pharmaceuticals will award $US2.75 million in funding through the Bayer Hemophilia Awards Program (BHAP)

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.504, 2006-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bayer Healthcare issues important Trasylol safety info

By  

Reactions Weekly, Vol. 1, Iss. 1091, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The US FDA has asked Bayer to add a Boxed Warning to the labelling for nimodipine [Nimotop] capsules

By  

Reactions Weekly, Vol. 1, Iss. 1087, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The US National Institute of Allergies and Infectious Diseases has granted $US10 million in funding to pharmaceutical company Baxter Healthcare to develop a vaccine against the coronavirus causing severe acute respiratory syndrome

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

US health research funding slows

By  

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Support for safety of Aleve leaves Bayer pleased

By  

Reactions Weekly, Vol. 1, Iss. 1041, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite